Tendwa, M.B.; Chebon-Bore, L.; Lobb, K.; Musyoka, T.M.; Tastan Bishop, Ö.
Force Field Parameters for Fe2+4S2−4 Clusters of Dihydropyrimidine Dehydrogenase, the 5-Fluorouracil Cancer Drug Deactivation Protein: A Step towards In Silico Pharmacogenomics Studies. Molecules 2021, 26, 2929.
https://doi.org/10.3390/molecules26102929
AMA Style
Tendwa MB, Chebon-Bore L, Lobb K, Musyoka TM, Tastan Bishop Ö.
Force Field Parameters for Fe2+4S2−4 Clusters of Dihydropyrimidine Dehydrogenase, the 5-Fluorouracil Cancer Drug Deactivation Protein: A Step towards In Silico Pharmacogenomics Studies. Molecules. 2021; 26(10):2929.
https://doi.org/10.3390/molecules26102929
Chicago/Turabian Style
Tendwa, Maureen Bilinga, Lorna Chebon-Bore, Kevin Lobb, Thommas Mutemi Musyoka, and Özlem Tastan Bishop.
2021. "Force Field Parameters for Fe2+4S2−4 Clusters of Dihydropyrimidine Dehydrogenase, the 5-Fluorouracil Cancer Drug Deactivation Protein: A Step towards In Silico Pharmacogenomics Studies" Molecules 26, no. 10: 2929.
https://doi.org/10.3390/molecules26102929
APA Style
Tendwa, M. B., Chebon-Bore, L., Lobb, K., Musyoka, T. M., & Tastan Bishop, Ö.
(2021). Force Field Parameters for Fe2+4S2−4 Clusters of Dihydropyrimidine Dehydrogenase, the 5-Fluorouracil Cancer Drug Deactivation Protein: A Step towards In Silico Pharmacogenomics Studies. Molecules, 26(10), 2929.
https://doi.org/10.3390/molecules26102929